[静脉-静脉体外膜氧合（VV-ECMO）治疗COVID-19肺炎重症呼吸衰竭2例报告]。

IF 0.4 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

Laeknabladid Pub Date : 2025-05-01 DOI:10.17992/lbl.2025.05.841

Luis Gisli Rabelo, Sigurdur Ingi Magnusson, Carlos Magnus Rabelo, Bryndis Sigurdardottir, Inga Lara Ingvarsdottir, Tomas Gudbjartsson

{"title":"[静脉-静脉体外膜氧合（VV-ECMO）治疗COVID-19肺炎重症呼吸衰竭2例报告]。","authors":"Luis Gisli Rabelo, Sigurdur Ingi Magnusson, Carlos Magnus Rabelo, Bryndis Sigurdardottir, Inga Lara Ingvarsdottir, Tomas Gudbjartsson","doi":"10.17992/lbl.2025.05.841","DOIUrl":null,"url":null,"abstract":"Venovenous extracorporeal membrane oxygenation (VV-ECMO) therapy can be indicated as a last resort treatment in severe respiratory failure. It is a complex and resource demanding treatment that can pose challenges, particularly during a pandemic such as COVID-19. We report two cases of previously healthy, middle-aged men who suffered severe respiratory failure following COVID-19 pneumonia. Both patients required VV-ECMO therapy at a low-volume, geographically isolated center in Iceland, a country of 400,000 inhabitants. They recovered well after the VV-ECMO treatment and returned to full-time work approximately one year later.","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 5","pages":"225-229"},"PeriodicalIF":0.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Severe respiratory failure from COVID-19 pneumonia treated with venovenous extracorporeal membrane oxygenation (VV-ECMO) - two case reports].\",\"authors\":\"Luis Gisli Rabelo, Sigurdur Ingi Magnusson, Carlos Magnus Rabelo, Bryndis Sigurdardottir, Inga Lara Ingvarsdottir, Tomas Gudbjartsson\",\"doi\":\"10.17992/lbl.2025.05.841\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Venovenous extracorporeal membrane oxygenation (VV-ECMO) therapy can be indicated as a last resort treatment in severe respiratory failure. It is a complex and resource demanding treatment that can pose challenges, particularly during a pandemic such as COVID-19. We report two cases of previously healthy, middle-aged men who suffered severe respiratory failure following COVID-19 pneumonia. Both patients required VV-ECMO therapy at a low-volume, geographically isolated center in Iceland, a country of 400,000 inhabitants. They recovered well after the VV-ECMO treatment and returned to full-time work approximately one year later.\",\"PeriodicalId\":49924,\"journal\":{\"name\":\"Laeknabladid\",\"volume\":\"111 5\",\"pages\":\"225-229\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Laeknabladid\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17992/lbl.2025.05.841\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laeknabladid","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17992/lbl.2025.05.841","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

静脉-静脉体外膜氧合（VV-ECMO）治疗可作为严重呼吸衰竭的最后手段。这是一种复杂且需要资源的治疗方法，可能会带来挑战，特别是在COVID-19等大流行期间。我们报告了两例先前健康的中年男性在COVID-19肺炎后出现严重呼吸衰竭的病例。这两名患者都需要在冰岛一个小容量、地理上孤立的中心进行VV-ECMO治疗，冰岛是一个拥有40万人口的国家。他们在VV-ECMO治疗后恢复良好，大约一年后恢复全职工作。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Severe respiratory failure from COVID-19 pneumonia treated with venovenous extracorporeal membrane oxygenation (VV-ECMO) - two case reports].

Venovenous extracorporeal membrane oxygenation (VV-ECMO) therapy can be indicated as a last resort treatment in severe respiratory failure. It is a complex and resource demanding treatment that can pose challenges, particularly during a pandemic such as COVID-19. We report two cases of previously healthy, middle-aged men who suffered severe respiratory failure following COVID-19 pneumonia. Both patients required VV-ECMO therapy at a low-volume, geographically isolated center in Iceland, a country of 400,000 inhabitants. They recovered well after the VV-ECMO treatment and returned to full-time work approximately one year later.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Laeknabladid MEDICINE, GENERAL & INTERNAL-

CiteScore

0.50

自引率

25.00%

发文量

审稿时长

>12 weeks

期刊介绍： Læknablaðið er fræðirit sem birtir vísinda og yfirlitsgreinar og annað efni sem byggir á rannsóknum innan læknisfræði eða skyldra greina. Læknablaðið er gefið út af Læknafélagi Íslands. Blaðið er sent til allra félagsmanna. Það var fyrst gefið út árið 1904 en hefur komið samfellt út frá árinu 1915. Blaðið kemur út 11 sinnum á ári og er prentað í 2000 eintökum. Allt efni Læknablaðsins frá árinu 2000 er aðgengilegt á heimasíðu blaðsins á laeknabladid.is og er aðgangur endurgjaldslaus og öllum opinn.